Skip to main content
Top
Published in: Rheumatology International 6/2014

Open Access 01-06-2014 | Short Communication

The clinical profile of Kawasaki disease of children from three Polish centers: a retrospective study

Authors: Daiva Gorczyca, Jacek Postępski, Edyta Olesińska, Małgorzata Lubieniecka, Iwona Lachór-Motyka, Violetta Opoka-Winiarska, Anna Gruenpeter

Published in: Rheumatology International | Issue 6/2014

Login to get access

Abstract

Kawasaki disease (KD) is one of the most common vasculitides of childhood. The aim of this retrospective study is to determine the incidence of KD and to evaluate its presenting symptoms, clinical course, laboratory tests, and treatment in patients with complete KD and incomplete KD at three pediatric rheumatology centers in Poland from January 2011 to December 2012. A total of 27 Caucasian children (12 boys and 15 girls) with median age of 3 years (range 4 months–12 years) were included in this study. The incidence of complete versus incomplete KD was 17 (63 %) versus 10 (37 %) children, respectively. Patients with incomplete KD significantly less presented cervical lymphadenopathy (20 vs. 88.2 %; p = 0.00075), changes in extremities (30 vs. 76.5 %; p = 0.04), and bilateral nonpurulent conjunctivitis (60 vs. 100 %; p = 0.01). Cardiac assessments show that the majority of patients with KD have not got coronary artery aneurysms (CAA). The median time from the onset of symptoms to intravenous immunoglobulin (IVIG) infusion was 7 days for complete KD and 11 days for incomplete KD. IVIG delay in the incomplete KD had no effect on the incidence of CAA. In conclusion, there were no differences in demographic features, age of onset, and laboratory tests of patients with complete and incomplete KD. Patients with incomplete KD significantly rarely presented cervical lymphadenopathy, changes in extremities, and conjunctival injection. Electrocardiography is a sensitive test to recognize cardiac involvement in the acute phase of KD. Despite the fact that incomplete forms of presentation often delay diagnosis, in most patients treatment with IVIG can avoid complication of CAA.
Literature
1.
go back to reference Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 Nationwide Survey. J Epidemiol 22:216–221PubMedCentralPubMed Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 Nationwide Survey. J Epidemiol 22:216–221PubMedCentralPubMed
2.
go back to reference Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007. Pediatr Infect Dis J 29:483–488PubMed Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007. Pediatr Infect Dis J 29:483–488PubMed
3.
go back to reference Heuclin T, Dubos F, Hue V, Godart F, Francart C, Vincent P (2009) Hospital network for evaluating the management of common childhood diseases, Martinot A. increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. J Pediatr 155:695–699PubMedCrossRef Heuclin T, Dubos F, Hue V, Godart F, Francart C, Vincent P (2009) Hospital network for evaluating the management of common childhood diseases, Martinot A. increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. J Pediatr 155:695–699PubMedCrossRef
4.
go back to reference Salo E, Griffiths EP, Farstad T, Schiller B, Nakamura Y, Yashiro M, Uehara R, Best BM, Burns JC (2012) Incidence of Kawasaki disease in northern European countries. Pediatr Int 54:770–772PubMedCentralPubMedCrossRef Salo E, Griffiths EP, Farstad T, Schiller B, Nakamura Y, Yashiro M, Uehara R, Best BM, Burns JC (2012) Incidence of Kawasaki disease in northern European countries. Pediatr Int 54:770–772PubMedCentralPubMedCrossRef
5.
go back to reference Fischer TK, Holman RC, Yorita KL, Belay ED, Melbye M, Koch A (2007) Kawasaki syndrome in Denmark. Pediatr Infect Dis J 26:411–415PubMedCrossRef Fischer TK, Holman RC, Yorita KL, Belay ED, Melbye M, Koch A (2007) Kawasaki syndrome in Denmark. Pediatr Infect Dis J 26:411–415PubMedCrossRef
6.
go back to reference Schiller B, Fasth A, Bjorkhem G, Elinder G (1995) Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr 84:769–774PubMedCrossRef Schiller B, Fasth A, Bjorkhem G, Elinder G (1995) Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr 84:769–774PubMedCrossRef
7.
go back to reference Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young; American Heart Association, American Academy of Pediatrics (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, Endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association. Circulation 110:2747–2771PubMedCrossRef Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young; American Heart Association, American Academy of Pediatrics (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, Endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association. Circulation 110:2747–2771PubMedCrossRef
8.
go back to reference Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, Burns JC (2011) Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J 30:1022–1026PubMedCentralPubMedCrossRef Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, Burns JC (2011) Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J 30:1022–1026PubMedCentralPubMedCrossRef
9.
go back to reference Uehara R, Yashiro M, Oki I, Nakamura Y, Yanagawa H (2007) Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey. Pediatr Int 49:427–430PubMedCrossRef Uehara R, Yashiro M, Oki I, Nakamura Y, Yanagawa H (2007) Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey. Pediatr Int 49:427–430PubMedCrossRef
10.
go back to reference Lin YT, Manlhiot C, Ching JC, Han RK, Nield LE, Dillenburg R, Pepelassis D, Lai LS, Smythe JF, Chahal N, Yeung RS, McCrindle BW (2010) Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006. Pediatr Int 52:699–706PubMedCrossRef Lin YT, Manlhiot C, Ching JC, Han RK, Nield LE, Dillenburg R, Pepelassis D, Lai LS, Smythe JF, Chahal N, Yeung RS, McCrindle BW (2010) Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006. Pediatr Int 52:699–706PubMedCrossRef
11.
go back to reference Corinaldesi E, Fabi M, Capra L, Landini Ch, Marino F (2012) A retrospective study of Kawasaki disease in a cohort of patients from Emilia Romagna, Italy, 2000–2010. Pediatr Int 54:40 Corinaldesi E, Fabi M, Capra L, Landini Ch, Marino F (2012) A retrospective study of Kawasaki disease in a cohort of patients from Emilia Romagna, Italy, 2000–2010. Pediatr Int 54:40
12.
go back to reference Al-Ammouri I, Al-Wahsh S, Khuri-Bulos N (2012) Kawasaki disease in Jordan: demographics, presentation, and outcome. Cardiol Young 22:390–395PubMedCrossRef Al-Ammouri I, Al-Wahsh S, Khuri-Bulos N (2012) Kawasaki disease in Jordan: demographics, presentation, and outcome. Cardiol Young 22:390–395PubMedCrossRef
13.
go back to reference Burns JC, Wiggins JW Jr, Toews WH, Newburger JW, Leung DY, Wilson H, Glodé MP (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759–763PubMedCrossRef Burns JC, Wiggins JW Jr, Toews WH, Newburger JW, Leung DY, Wilson H, Glodé MP (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759–763PubMedCrossRef
14.
go back to reference Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RS (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171:657–662PubMedCrossRef Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RS (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171:657–662PubMedCrossRef
15.
go back to reference Ghelani SJ, Sable C, Wiedermann BL, Spurney CF (2012) Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American heart association guidelines. Pediatr Cardiol 33:1097–1103PubMedCrossRef Ghelani SJ, Sable C, Wiedermann BL, Spurney CF (2012) Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American heart association guidelines. Pediatr Cardiol 33:1097–1103PubMedCrossRef
16.
go back to reference Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 168:1315–1321PubMedCrossRef Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 168:1315–1321PubMedCrossRef
17.
go back to reference Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr 168:157–162PubMedCrossRef Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr 168:157–162PubMedCrossRef
18.
go back to reference Falcini F, Ozen S, Magni-Manzoni S, Candelli M, Ricci L, Martini G, Cuttica RJ, Oliveira S, Calabri GB, Zulian F, Pistorio A, La Torre F, Rigante D (2012) Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study. Clin Exp Rheumatol 30:799–804PubMed Falcini F, Ozen S, Magni-Manzoni S, Candelli M, Ricci L, Martini G, Cuttica RJ, Oliveira S, Calabri GB, Zulian F, Pistorio A, La Torre F, Rigante D (2012) Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study. Clin Exp Rheumatol 30:799–804PubMed
20.
go back to reference Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, Lee J (2012) Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr. doi:10.1007/s00431-012-1891-5 PubMed Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, Lee J (2012) Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr. doi:10.​1007/​s00431-012-1891-5 PubMed
21.
go back to reference Crystal MA, Syan SK, Yeung RSM, Dipchand AI, McCrindle BW (2008) Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease. Can J Cardiol 24:776–780PubMedCentralPubMedCrossRef Crystal MA, Syan SK, Yeung RSM, Dipchand AI, McCrindle BW (2008) Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease. Can J Cardiol 24:776–780PubMedCentralPubMedCrossRef
22.
go back to reference Kuriki M, Fujino M, Tanaka K, Horio K, Kusuki H, Hosoi M, Eryu Y, Kato T, Yamazaki T, Hata T (2011) Ventricular repolarization lability in children with Kawasaki disease. Pediatr Cardiol 32:487–491PubMedCentralPubMedCrossRef Kuriki M, Fujino M, Tanaka K, Horio K, Kusuki H, Hosoi M, Eryu Y, Kato T, Yamazaki T, Hata T (2011) Ventricular repolarization lability in children with Kawasaki disease. Pediatr Cardiol 32:487–491PubMedCentralPubMedCrossRef
23.
go back to reference Printz BF, Sleeper LA, Newburger JW, Minich LL, Bradley T, Cohen MS, Frank D, Li JS, Margossian R, Shirali G, Takahashi M, Colan SD (2011) Pediatric heart network investigators. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol 57:86–92PubMedCentralPubMedCrossRef Printz BF, Sleeper LA, Newburger JW, Minich LL, Bradley T, Cohen MS, Frank D, Li JS, Margossian R, Shirali G, Takahashi M, Colan SD (2011) Pediatric heart network investigators. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol 57:86–92PubMedCentralPubMedCrossRef
24.
go back to reference Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, Sonobe T, Nakamura Y (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171:651–656PubMedCrossRef Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, Sonobe T, Nakamura Y (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171:651–656PubMedCrossRef
Metadata
Title
The clinical profile of Kawasaki disease of children from three Polish centers: a retrospective study
Authors
Daiva Gorczyca
Jacek Postępski
Edyta Olesińska
Małgorzata Lubieniecka
Iwona Lachór-Motyka
Violetta Opoka-Winiarska
Anna Gruenpeter
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 6/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2836-7

Other articles of this Issue 6/2014

Rheumatology International 6/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.